HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome.

AbstractOBJECTIVES:
In case of inoperability or refusal of surgery, stereotactic body radiation therapy (SBRT) is the most effective treatment for a stage I non-small cell lung carcinoma (NSCLC). The results obtained by this irradiation technique are considerably superior to those observed in the time of conventional 3D irradiation and its toxicities are much less important, which makes it possible in elderly patients, or those presenting cardio-pulmonary comorbidities and a poor perfomance status.
MATERIALS AND METHODS:
This study is a retrospective analysis of 90 patients who underwent SBRT for a stage I NSCLC between 2010 and 2015. Its purpose is to describe its effectiveness in term of overall survival (OS), specific survival (SS), local control (LC), regional control (RC) and metastatic control (MC) as well as their prognostic factors, and its tolerance.
RESULTS:
LC, RC, MC as well as OS and SS rate at 4 years were comparable to the main prospective studies, respectively 89%, 92%, 70%, 33% and 66%. No LC prognostic factor could be identified. Radiation pneumonitis was observed with a rate of 61.5%, of which 56% were asymptomatic, and 4% of the patients had a rib fracture.
CONCLUSIONS:
SBRT is an efficient and well-tolerated treatment for stage I non-small cell lung carcinomas.
AuthorsI Menoux, D Antoni, P Truntzer, A Keller, G Massard, G Noël
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 126 Pg. 201-207 (12 2018) ISSN: 1872-8332 [Electronic] Ireland
PMID30527188 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung (pathology, radiotherapy)
  • Disease-Free Survival
  • Female
  • Humans
  • Lung Neoplasms (pathology, radiotherapy)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Outcome Assessment, Health Care
  • Prognosis
  • Radiation Dose Hypofractionation
  • Radiation Pneumonitis (etiology)
  • Radiosurgery (adverse effects, methods)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: